Document is current
Any future updates will be listed below
-
Authors
Liu, Ya-nan
Lv, Xue
Chen, Xin
Yan, Meng
Guo, Ling-chuan
Liu, Gang
Yao, Liu
Jiang, Hong-feng https://orcid.org/0000-0002-1600-3236
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81970392, 82070305, 82100268)
Natural Science Foundation of Beijing Municipality (J190010)
Tianjin Natural Science Foundation of China (19JCQNJC10100)
- License Information
-
More Information
Article History
Received: 6 April 2022
Accepted: 17 May 2022
First Online: 16 June 2022
Declarations
:
: The animal study was reviewed and approved by the Committee of Tianjin Medical University on Animal Experimentation (TMUaMEC2021014). All protocols were approved by the First Affiliated Hospital of Soochow University Ethics Committee.
: AAA is highly lethal disease in humans. This study suggests that early boosting of YAP-LTBP4 pathway in patients with AAA might be an effective strategy to protect against lethality by reducing the risk of aneurysm rupture.
: The authors declare no competing interests.
